OXYGEN MEDICINAL GASEOUS

Ukraine

It is used for diseases accompanied by oxygen starvation (hypoxia), such as pneumonia, pulmonary edema, bronchial asthma, heart failure, and coronary insufficiency. The drug is also used in cases of poisoning by carbon monoxide, cyanide, or asphyxiating gases, during general anesthesia, and in the postoperative period.

Brand name OXYGEN MEDICINAL GASEOUS
Dosage form gas
Active substance / Dosage
oxygen · not less than 99.5 percent
Prescription type prescription only
ATC code
Registration number UA/18474/01/01
Manufacturer LLC "Tekhnohaz-S"
OXYGEN MEDICINAL GASEOUS gas

Frequently asked questions

How should Oxygen medicinal gaseous be taken correctly?

In hospitals, it is usually inhaled through special masks connected to cylinders. At home, special containers (pillows) are used. Most commonly, inhalations of a mixture with air at a concentration of 40–60% at a volume of 4–5 liters per minute are applied. It is recommended to use the agent together with humidifiers.

What side effects can Oxygen medicinal gaseous cause?

Some people may experience dizziness, nausea, coughing, irritation or increased dryness of the mucous membranes, as well as individual hypersensitivity to oxygen. In case of overdose, vomiting and seizures are possible.

Who should not use this drug?

Contraindications include acute respiratory diseases, the presence of cavities in the lungs, severe forms of arterial hypertension, neoplasms, a history of epileptic seizures, impaired patency of the auditory canals, as well as increased individual sensitivity to oxygen.

Can the drug be used during pregnancy or breastfeeding?

The agent should not be used during pregnancy for a term exceeding 5 months. Breastfeeding should be discontinued for the period of drug use.

Does the drug affect the ability to drive a vehicle?

Due to the possible occurrence of dizziness, one should refrain from driving a car or performing work that requires high concentration and rapid reaction.

How can other medicines interact with oxygen?

Nitrates, adrenoblockers, calcium ion antagonists, and nootropics may promote better oxygen utilization by tissues, which helps to reduce oxygen deficiency.

Instructions for use

INSTRUCTIONS
for medical use of medicinal product

MEDICAL OXYGEN GAS
(OXYGEN GAS MEDICAL)

Composition:

active substance: oxygen;

contains not less than 99.5% oxygen.

Pharmaceutical form. Gas.

Main physico-chemical properties: colorless, odorless and tasteless gas, supports combustion more actively than air, strong oxidizing agent.

Pharmacotherapeutic group.

Medical gases.

ATC Code V03AN01.

Pharmacological properties.

Pharmacodynamics.

Oxygen belongs to the group of anti-hypoxic and antioxidant agents. It has the ability to bind with blood hemoglobin in the lungs and be transported as a complex compound with heme to the body's cells. Oxygen is a strong oxidizing agent and an essential element in metabolic transformations of carbohydrates, proteins, and fats into energy required to sustain vital functions of the organism.

Pharmacokinetics.

In the human body, oxygen diffuses through lung tissue into the blood, binding to hemoglobin in erythrocytes and partially dissolving in plasma. Oxygen is then transported to body tissues, where it diffuses into interstitial tissue fluid. The final stage of respiration is utilization of oxygen in biological oxidation processes to produce cellular energy, after which, following a series of transformations, it is exhaled by the lungs in bound form as carbon dioxide (CO2).

Clinical characteristics.

Indications.

Conditions associated with hypoxia:

respiratory system:

  • pneumonia;
  • pulmonary edema;
  • bronchial asthma;
  • pneumosclerosis;

cardiovascular system:

  • heart failure;
  • coronary insufficiency.

Poisonings:

  • carbon monoxide;
  • hydrogen cyanide;
  • suffocating gases.

Used during general anesthesia in combination with inhalational anesthetics; in the postoperative period.

Used for preparation of oxygen cocktails and foams.

Contraindications.

Contraindications for hyperbaric oxygenation include acute respiratory diseases, history of epileptiform seizures, impaired patency of auditory tubes and canals connecting paranasal sinuses, presence of lung cavities, bronchopleural fistulas, severe forms of arterial hypertension, neoplasms, and increased individual sensitivity to oxygen.

Interaction with other medicinal products and other types of interactions.

Nitrates, beta-blockers, calcium ion antagonists, and nootropics promote more economical tissue utilization of oxygen, improve its utilization, thereby reducing hypoxia and increasing the body's resistance to oxygen deficiency.

Special precautions.

Use with humidifiers is recommended.

Do not use during menstruation.

Use during pregnancy or breastfeeding.

Do not use during pregnancy beyond 5 months.

During use of the medicinal product, breastfeeding should be discontinued.

Ability to influence reaction rate when driving or operating machinery.

Due to possible dizziness, avoid driving a car or performing work requiring increased attention and rapid reaction.

Method of administration and dosage.

In hospital settings, oxygen is most commonly administered via inhalation through special rubber or plastic masks connected directly to steel oxygen cylinders.

In outpatient practice and at home, special rubber or plastic containers (bags) filled with oxygen or its mixture are more frequently used.

For hyperbaric oxygenation, i.e., oxygen delivery under increased pressure, special ventilated chambers, so-called hyperbaric chambers, are used, where oxygen is administered via inhalation as well as through mucous membranes and skin.

Most commonly, oxygen is administered by inhalation as a mixture with air at concentrations of 40–60% at a flow rate of 4–5 liters per minute. A mixture known as "carbogen," consisting of 95% oxygen and 5% carbon dioxide, is also used. The mixture is usually administered humidified.

During hyperbaric oxygenation, oxygen is administered under pressure of 1.2–2 atm. For therapeutic purposes, 8–10 sessions are typically conducted.

Preparation of oxygen cocktails and foams: oxygen is mixed with food products, juices, and herbal infusions.

Children.

The medicinal product is used in pediatric practice.

Overdose.

In case of overdose, nausea, vomiting, and convulsions may occur. Treatment is symptomatic.

Side effects.

In some patients, individual hypersensitivity to oxygen and its mixtures is possible, as well as dizziness, nausea, increased dryness of mucous membranes, their irritation, cough.

If any adverse events occur, consult a physician.

Shelf life.

1.5 years.

The medicinal product must not be used after the expiry date stated on the packaging.

Storage conditions.

Store in a place protected from direct sunlight, at a temperature not exceeding 50 °C. Avoid contact with open flame and heat sources. Do not allow contact with oils. Do not drop.

Packaging.

2 L, 3 L, 5 L, 8 L, 10 L, 12 L, 40 L, 50 L in cylinders.

Prescription status.

By prescription only.

Manufacturer.

Limited Liability Company "Tekhnogaz-S".

Manufacturer's address and place of business.

58, Brytanska Street, Sumy, Ukraine, 40004.

Similar drugs

Brand name Dosage form Active substance / Dosage Manufacturer
OXYGEN MEDICINAL GASEOUS gas
oxygen · not less than 99.5 percent
PJSC "Lviv Chemical Plant"
OXYGEN MEDICINAL GASEOUS gas
oxygen · not less than 99.5 percent
PJSC "Poltava Medical Glass Plant"
OXYGEN MEDICINAL GASEOUS gas
oxygen · 99.5 percent
Sector Gazu LLC
OXYGEN MEDICINAL GASEOUS gas
oxygen · not less than 99.5 percent
State Enterprise "Scientific and Production Complex for Gas Turbine Building "Zorya"-Mashproekt"
OXYGEN MEDICINAL GASEOUS gas
oxygen · not less than 99.5 percent
DPI Air Gas LLC
OXYGEN MEDICINAL GASEOUS gas
oxygen · not less than 99.5 percent
Limited Liability Company "Zaporizhskyy Avtohenyi Zavod" and Company
OXYGEN MEDICINAL GASEOUS gas
oxygen · not less than 99.5 percent
Sumy Machine-Building Scientific Production Association LLC
OXYGEN MEDICINAL GASEOUS gas
oxygen · not less than 99.5 percent
Subsidiary enterprise "Messer Ukraina" (responsible for batch release; full production cycle, except batch release)
OXYGEN MEDICINAL GASEOUS gas
oxygen · not less than 99.5 percent
PJSC "Severodonetsk Association Azot"
OXYGEN MEDICINAL GASEOUS gas
oxygen · not less than 99.5 percent
JSC "National Atomic Energy Generating Company "Energoatom"
OXYGEN MEDICINAL GASEOUS gas
oxygen · not less than 99.5 percent
State Enterprise "National Nuclear Power Generating Company "Energoatom"
OXYGEN MEDICINAL GASEOUS gas
oxygen · not less than 99.5 percent
JSC "National Atomic Energy Generating Company "Energoatom"

The original data is available in the language of the country of manufacture.

Data source: State Register of Medicinal Products of Ukraine

Data last verified: August 13, 2026